MCAP — MedCap AB (publ) Income Statement
0.000.00%
Last trade - 00:00
- SEK5.91bn
- SEK5.99bn
- SEK1.59bn
- 97
- 16
- 77
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 757 | 817 | 916 | 1,111 | 1,587 |
Cost of Revenue | |||||
Gross Profit | 337 | 366 | 457 | 529 | 738 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 674 | 728 | 789 | 940 | 1,360 |
Operating Profit | 83.2 | 89.1 | 127 | 171 | 228 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 72.2 | 81.5 | 117 | 152 | 222 |
Provision for Income Taxes | |||||
Net Income After Taxes | 57.6 | 64.5 | 98.1 | 118 | 173 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 53.7 | 60.9 | 96.5 | 118 | 172 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 53.7 | 60.9 | 96.5 | 118 | 172 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.1 | 4.37 | 6.52 | 8.07 | 12 |
Dividends per Share |